Rafferty Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.4M | Buy |
|
|||||
|
2025
Q1 | $34.3M | Sell |
|
|||||
|
2024
Q4 | $36.3M | Buy |
|
|||||
|
2024
Q3 | $40.1M | Sell |
|
|||||
|
2024
Q2 | $43.6M | Buy |
|
|||||
|
2024
Q1 | $33.2M | Buy |
|
|||||
|
2023
Q4 | $31.8M | Buy |
|
|||||
|
2023
Q3 | $26.8M | Buy |
|
|||||
|
2023
Q2 | $24.8M | Buy |
|
|||||
|
2023
Q1 | $20.5M | Buy |
|
|||||
|
2022
Q4 | $18.4M | Buy |
|
|||||
|
2022
Q3 | $17.8M | Buy |
|
|||||
|
2022
Q2 | $13.2M | Sell |
|
|||||
|
2022
Q1 | $15.2M | Buy |
|
|||||
|
2021
Q4 | $12M | Buy |
|
|||||
|
2021
Q3 | $8.55M | Buy |
|
|||||
|
2021
Q2 | $7.89M | Buy |
|
|||||
|
2021
Q1 | $8.08M | Buy |
|
|||||
|
2020
Q4 | $5.91M | Sell |
|
|||||
|
2020
Q3 | $6.94M | Buy |
|
|||||
|
2020
Q2 | $6.16M | Buy |
|
|||||
|
2020
Q1 | $3.72M | Sell |
|
|||||
|
2019
Q4 | $8.15M | Sell |
|
|||||
|
2019
Q3 | $8.74M | Buy |
|
|||||
|
2019
Q2 | $7.65M | Buy |
|
|||||
|
2019
Q1 | $7.21M | Buy |
|
|||||
|
2018
Q4 | $1.59M | Sell |
|
|||||
|
2018
Q3 | $2.13M | Buy |
|
|||||
|
2018
Q2 | $1.87M | Buy |
|
|||||
|
2018
Q1 | $1.5M | Sell |
|
|||||
|
2017
Q4 | $1.51M | Sell |
|
|||||
|
2017
Q3 | $2.28M | Sell |
|
|||||
|
2017
Q2 | $2.31M | Buy |
|
|||||
|
2017
Q1 | $1.37M | Sell |
|
|||||
|
2016
Q4 | $966K | Buy |
|
|||||
|
2016
Q3 | $690K | Buy |
|
|||||
|
2016
Q2 | $583K | Sell |
|
|||||
|
2016
Q1 | $750K | Buy |
|
|||||
|
2015
Q4 | $926K | Buy |
|
|||||
|
2015
Q3 | $716K | Sell |
|
|||||
|
2015
Q2 | $898K | Buy |
|
|||||
|
2015
Q1 | $798K | Buy |
|
|||||
|
2014
Q4 | $513K | Buy |
|
|||||
|
2014
Q3 | $344K | Buy |
|
|||||
|
2014
Q2 | $236K | Sell |
|
|||||
|
2014
Q1 | $316K | Buy |
|
|||||
|
2013
Q4 | $270K | Buy |
|